Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MN”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Testing effectiveness (Phase 2)Study completedNCT00001031
What this trial is testing

A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 296
Early research (Phase 1)Study completedNCT00805753
What this trial is testing

Dose-Finding Pilot Study of ACTH in Patients With Idiopathic Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Mayo Clinic 20
Early research (Phase 1)Study completedNCT00000853
What this trial is testing

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of Low Dose MN rsgp120/HIV-1 (Genentech) in Combination With QS21 Adjuvant or Alum in Healthy Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 37
Early research (Phase 1)Study completedNCT00000846
What this trial is testing

A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection, in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally, in HIV-1 Uninfected Volunteers.

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Not applicableLooking for participantsNCT07037927
What this trial is testing

Minnesota RETAIN Phase 3

Who this might be right for
Injuries Related WorkIllness Related WorkDisability
Mayo Clinic 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT05050214
What this trial is testing

Obinutuzumab in Primary MN

Who this might be right for
Membranous Nephropathy
Mario Negri Institute for Pharmacological Research 20
Early research (Phase 1)Study completedNCT00000813
What this trial is testing

A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox-gp160 MN (ALVAC vCP125, HIV-1 gp160 MN) in HIV-1 Uninfected Adult Volunteers

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 28
Not applicableUnknownNCT05667883
What this trial is testing

Prognostic Model of GC/CTX in the Treatment of MN

Who this might be right for
Idiopathic Membranous Nephropathy
Qianfoshan Hospital 50
Not applicableUnknownNCT05383547
What this trial is testing

Bortezomib for Treating Glomerular Diseases

Who this might be right for
BortezomibGlomerulonephritisMN+3 more
Ruijin Hospital 20
Not applicableUnknownNCT06189599
What this trial is testing

Modified antioxIdants Bacteria for Gut Inflammation

Who this might be right for
Chronic Inflammatory Small Bowel Disease
Assistance Publique - Hôpitaux de Paris 500
Not applicableStudy completedNCT05148455
What this trial is testing

Pregnancy-related Changes in Melanocytic Nevi

Who this might be right for
Melanocytic Nevi (MN)
University Hospital, Basel, Switzerland 50
Early research (Phase 1)Ended earlyNCT00460460
What this trial is testing

Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies

Who this might be right for
Lymphoma
AstraZeneca 75
Testing effectiveness (Phase 2)Ended earlyNCT04154787
What this trial is testing

Efficacy and Safety of LNP023 Compared With Rituximab in Subjects With Idiopathic Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Novartis Pharmaceuticals 37
Not applicableNot Yet RecruitingNCT07319793
What this trial is testing

Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCT

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes (MDS)
Peking University People's Hospital 200
Early research (Phase 1)Study completedNCT00001041
What this trial is testing

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Study completedNCT00011037
What this trial is testing

ALVAC-HIV vCP1452 Alone and Combined With MN rgp120

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 160
Not applicableUnknownNCT05656963
What this trial is testing

The Influencing Factors and Mechanism of High Incidence of Thrombotic Events in Patients With MN and DKD

Who this might be right for
Glomerulonephritis, MembranousDiabetic NephropathiesThrombelastography+1 more
Yipeng Liu 741
Not applicableUnknownNCT01253057
What this trial is testing

A Research on the Hospital Pollution Control and Hygine Intervention of Chemotherapy Drugs Exposure

Who this might be right for
Sister-chromatic-exchange(SCE)Micronuclei(MN)
Taipei Medical University WanFang Hospital 200
Not applicableUnknownNCT05667909
What this trial is testing

Prognostic Model of Rituximab in the Treatment of MN

Who this might be right for
Idiopathic Membranous Nephropathy
Qianfoshan Hospital 50
Not applicableUnknownNCT05667896
What this trial is testing

Prognostic Model of GC/TAC in the Treatment of MN

Who this might be right for
Idiopathic Membranous Nephropathy
Qianfoshan Hospital 50
Load More Results